Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00025-9/fulltext?dgcid=hubspot_update_feature_updatealerts_lanmic&utm_campaign=update-lanmic&utm_medium=email&_hsenc=p2ANqtz-88PDGctHIeG8UMNcc2pehun0vkAc0HIgCLdVPgHX0RhlmslZB90DnAW09UrfVHH20rSCzOYYNd0-NOGEeP-Y2P73idvw&_hsmi=316006496&utm_content=315506556&utm_source=hs_email